This inventor holds 4 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent. Top assignees: Betta Pharmaceuticals Co., Ltd., Beijing Semidrive Technology Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 19 
1 out of 2 Years Active: 2022-2026
Title: Innovations of Xiaofeng Xu
Introduction
Xiaofeng Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bromodomain protein inhibitors. With a total of 4 patents to his name, his work is recognized for its potential impact on therapeutic applications.
Latest Patents
Xiaofeng Xu's latest patents include a compound functioning as a bromodomain protein inhibitor. This invention relates to a bromodomain inhibitor and provides compositions and formulations comprising such compounds. Additionally, it outlines methods of using and preparing these compounds, showcasing his innovative approach to drug development.
Career Highlights
Xiaofeng Xu is associated with Betta Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work at this company highlights his commitment to improving healthcare through innovative solutions.
Collaborations
Some of his notable coworkers include Jiabing Wang and Lieming Ding, who contribute to the collaborative environment that fosters innovation within their projects.
Conclusion
Xiaofeng Xu's contributions to the field of pharmaceuticals, particularly through his patents on bromodomain protein inhibitors, demonstrate his role as a key innovator in the industry. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile